Percutaneous transhepatic stenting of a restrictive atrial septal communication in hypoplastic left heart syndrome

Khalfan Al Senaidi1, Abdulrahman Al Mesned, James Y Coe

  • 1Division of Pediatric Cardiology, Sultan Qaboos University, Sultanate of Oman.

Insights

Successful transhepatic venous stenting of a restrictive atrial septal defect in an infant with hypoplastic left heart syndrome (HLHS) provided a vital alternative access route for cardiac catheterization interventions.

Area of Science:

  • Pediatric Cardiology
  • Interventional Cardiology
  • Congenital Heart Disease

Background:

  • Postnatal survival in infants with hypoplastic left heart syndrome (HLHS) relies on ductus arteriosus patency and an unrestrictive atrial septal defect (ASD).
  • Restrictive ASDs can compromise pulmonary and systemic blood flow, necessitating intervention.

Observation:

  • A six-week-old infant presented with HLHS, tricuspid valve regurgitation, and a restrictive ASD.
  • Initial attempts at transfemoral balloon atrial septostomy provided only temporary relief and were not repeatable.

Findings:

  • A transhepatic venous approach was successfully employed to stent the restrictive atrial communication.
  • This technique allowed for the use of a large delivery system (≥ 8 Fr), crucial for complex interventions.

Implications:

  • The transhepatic venous approach offers a viable alternative access route for infant cardiac catheterization when traditional methods fail.
  • This technique expands interventional options for neonates and infants with complex congenital heart defects requiring large-bore access.